Philip Morris posted solid Q2 2026 results, achieving 7.6% organic net revenue growth and strong momentum in its smoke-free product segment. Despite this, concerns remain as revenue from combustible products also rose, indicating a slower shift away from traditional tobacco. Additionally, the U.S. market underperformed, and the company lowered two of its three earnings forecasts, which could weigh on its valuation. The stock rose 3.3% after the report, reflecting investor optimism amid mixed signals about future growth.
Philip Morris International reported a record Q2 2026 net revenue of $11.19 billion, supported by 15.2% adjusted earnings per share growth and expanding profit margins. Smoke-free products, including IQOS and ZYN, now make up 42% of the company's rev...
Analyst firm BTIG initiated a Buy rating on Philip Morris International, with the stock trading at $188.04. They project strong Q2 earnings of $2.05 per share and revenue growth to $10.64 billion, up from last year. The company also offers an attract...
